Product
BEBT-503
1 clinical trial
1 indication
Indication
Healthy SubjectsClinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Orally Administered BEBT-503 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses (SAD) and Multiple Ascending Doses (MAD) in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-05-29